לוסק 20 מג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

OMEPRAZOLE

Disponível em:

ABIC LTD.

Código ATC:

A02BC01

Forma farmacêutica:

קפסולות

Composição:

OMEPRAZOLE 20 MG

Via de administração:

פומי

Tipo de prescrição:

אין צורך במרשם

Fabricado por:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Grupo terapêutico:

OMEPRAZOLE

Área terapêutica:

OMEPRAZOLE

Indicações terapêuticas:

Relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

Data de autorização:

2020-12-31

Folheto informativo - Bula

LOSEC_Capsules_20mg_OTC_ SZ_10.07.2023_Notification
ʥ"ʮʹʺʤ (ʭʩʸʩʹʫʺ) ʭʩʧʷʥʸʤ ʺʥʰʷʺ ʩʴʬ
ʯʫʸʶʬ ʯʥʬʲ
-
986
1
ʠʴʥʸ ʭʹʸʮ ʠʬʬ ʺʷʥʥʹʮ ʤʴʥʸʺʤ
ʷʱʥʬ

20
ʢ"ʮ
ʺʥʱʥʮʫ
ʡʫʸʤ
:ʤʬʩʫʮ ʤʱʥʮʫ ʬʫ
ʬʥʦʸʴʮʥʠ
20
ʮ
ʢ"
Omeprazole 20 mg)
(
ʳʩʲʱ ʤʠʸ ʭʩʩʰʢʸʬʠʥ ʭʩʬʩʲʴ ʩʺʬʡ
ʭʩʡʩʫʸʮ ʬʲ ʲʣʩʮʬ
2
"ʤʴʥʸʺʤ ʬʹ ʭʩʡʩʫʸʮʤʮ ʷʬʧ ʬʲ ʡʥʹʧ ʲʣʩʮ"
ʳʩʲʱʥ
6
-
."ʳʱʥʰ ʲʣʩʮ"
.ʤʴʥʸʺʡ ʹʮʺʹʺ ʭʸʨʡ ʥʴʥʱ ʣʲ ʯʥʬʲʤ ʺʠ
ʯʥʩʲʡ ʠʸʷ
ʹʩ ʭʠ .ʤʴʥʸʺʤ ʬʲ ʩʺʩʶʮʺ ʲʣʩʮ ʬʩʫʮ ʤʦ
ʯʥʬʲ
.ʧʷʥʸʤ ʬʠ ʥʠ ʠʴʥʸʤ ʬʠ ʤʰʴ ,ʺʥʴʱʥʰ ʺʥʬʠʹ
ʪʬ
ʪʩʬʲ
ʺʠ ʬʥʨʩʬ
ʤʴʥʸʺʤ
ʬʲ
-
ʤʦ ʯʥʬʲʡ ʯʥʰʩʮʤ ʳʩʲʱʡ ʺʥʠʸʥʤʤ ʩʴ
.ʳʱʥʰ ʲʣʩʮʬ ʷʥʷʦ ʪʰʩʤ ʭʠ ʧʷʥʸʡ ʵʲʥʥʩʤ .
ʺʥʰʴʬ ʪʩʬʲ
ʤʣʩʮʡ ʠʴʥʸʬ
ʩʰʩʮʱʺʥ
ʭʩʸʴʺʹʮ ʭʰʩʠ ʥʠ ʭʩʸʩʮʧʮ (ʭʩʮʥʨʴʮʩʱ)
ʤʬʧʮʤ
.
1
.
?ʤʴʥʸʺʤ ʺʣʲʥʩʮ ʤʮʬ
ʺʡʫʲʮ ʤʴʥʸʺʤ
.ʬʥʫʩʲʤ ʺʫʸʲʮʡ ʤʶʮʥʧ ʺʹʸʴʤ
ʣʲʥʩʮ ʷʱʥʬ
ʺ
ʸʺʥʩ ʥʠ ʲʥʡʹʡ ʭʩʩʮʲʴ ʬʹ ʺʥʸʩʣʺʡ
ʭʩʲʩʴʥʮʤ (ʺʡʸʶ ʤʮʢʥʣʬ) ʸʦʥʧ ʭʸʦ
ʩʰʩʮʱʺʡ ʤʬʷʤʬ
ʭʩʬʴʥʨʮʡ
ʬʩʢ ʬʲʮ
18
ʭʩʰʹ
.
:ʺʩʨʩʥʴʸʺ ʤʶʥʡʷ
ʭʩʰʥʨʥʸʴ ʺʡʠʹʮ ʩʡʫʲʮ
)
Proton Pump Inhibitor (PPI)
(
.
2
.
ʤʴʥʸʺʡ ʹʥʮʩʹʤ ʩʰʴʬ
:ʭʠ ʸʩʹʫʺʡ ʹʮʺʹʤʬ ʯʩʠ

ʬʩʲʴʤ ʸʮʥʧʬ (ʩʢʸʬʠ) ʹʩʢʸ ʤʺʠ
,
,ʬʥʦʸʴʮʥʠ
ʤʬʩʫʮ ʸʹʠ ʭʩʴʱʥʰʤ ʭʩʡʩʫʸʮʤʮ ʣʧʠ ʬʫʬ ʥʠ
ʤʠʸ) ʤʴʥʸʺʤ
ʳʩʲʱ
6
-
"ʳʱʥʰ ʲʣʩʮ"
(
.

ʹʩʢʸ ʤʺʠ
(ʩʢʸʬʠ)
ʺʥʬʩʫʮʤ ʺʥʴʥʸʺʬ
ʭʩʰʥʨʥʸʴ ʺʡʠʹʮ ʩʡʫʲʮ
)
PPI
,ʬʥʦʸʴʥʨʰʴ :ʯʥʢʫ) ʭʩʸʧʠ (
.(ʬʥʦʸʴʮʥʱʠ ,ʬʥʦʸʴʡʠʸ ,ʬʥʦʸʴʥʱʰʬ

ʤʺʠ
ʬʨʥʰ
ʤʬʩʫʮʤ ʤʴʥʸʺ
ʤʴʥʸʺ) ʸʩʡʰʩʴʬʰ
ʬʥʴʩʨʬ